Common Childhood Virus Poses Threat To Adults, Research Shows

and less than 40 years old.

While 135 patients tested positive for RSV antibodies, only the 57 whose level of antibodies quadrupled over the course of a month were considered true cases of RSV for the study. In some patients, researchers noticed the effects of bacterial infection, which indicates they might have acquired a bacterial pneumonia along with or after RSV infection.

“Doctors used to think that adults who acquire RSV may get cold symptoms, not pneumonia,” said Murry. “But in fact, a third of the 57 RSV patients in this study had changes in their lung X-rays which were probably RSV-related.”

The RSV virus attacks the epithelial cells that line the airways in the lungs. It spreads as people cough up infected epithelial cells, so hand washing is the best way to limit the spread of RSV.

RSV is the leading cause of severe lower respiratory tract infection in infants and young children. According to Murry, nearly every child in the United States acquires RSV before the age of two, as their immune systems are developing. Adults most vulnerable to infection are those who have undergone chemotherapy or organ transplants, as well as those with HIV.

If a patient has a severe enough case of RSV to need the help of a breathing machine, doctors can treat the infection with Ribovarin, an anti-viral drug. Doctors dissolve the drug in saline, and patients inhale it through a mist.

Symptoms of RSV persist even after the patient is discharged from the hospital.

“When people go home, it may be a while before they feel completely better, because the damage to their airways will take at least 8 weeks to heal,” said Murry. “So they’ll remain kind of wheezy and a little short of breath for that time. Most people can go back to work as soon as they go home from the hospital.”

Murry said a normal person couldn’t easily tell whether they have RSV or just a nasty cold. One clue i

Contact: Andrew R. Murry
Ohio State University

Page: 1 2 3

Related biology news :

1. Common cold virus can cause polio in mice when injected into muscles
2. Common call for action on European Research Council (ERC)
3. Common therapy for HIV associated with cervical abnormality regression
4. Common chemicals morphing into potential toxins in Arctic
5. Common worm provides insights into salmonella virulence
6. Common virus may contribute to uncommon bone disease in children
7. Common airborne substance makes asthmatics more sensitive to house dust mites: study
8. Common genetic damages in non-dividing cells lead to the creation of mutant proteins
9. Common nutrients fed to pregnant mice altered their offsprings coat color
10. Common treatment for depression is safe and effective for Alzheimers patients
11. Common gene variant increases risk of atherosclerosis

Post Your Comments:

(Date:11/17/2015)... 17, 2015 Paris ... --> Paris , qui s,est ... DERMALOG, le leader de l,innovation biométrique, a inventé le ... et empreintes sur la même surface de balayage. Jusqu,ici, ... l,autre pour les empreintes digitales. Désormais, un seul scanner ...
(Date:11/17/2015)... , Nov. 17, 2015 Pressure BioSciences, Inc. ... the development and sale of broadly enabling, pressure cycling ... sciences industry, today announced it has received gross proceeds ... million Private Placement (the "Offering"), increasing the total amount ... or more additional closings are expected in the near ...
(Date:11/12/2015)... Nov. 12, 2015  A golden retriever that stayed ... dystrophy (DMD) has provided a new lead for treating ... the Broad Institute of MIT and Harvard and the ... . Cell, pinpoints a protective ... the disease,s effects. The Boston Children,s lab of ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... Malaysia , Nov. 24, 2015  Asia-Pacific ... contract research organisation (CRO) market. The trend of ... in lower margins but higher volume share for ... capacity and scale, however, margins in the CRO ... Organisation (CRO) Market ( http://www.frost.com/sublib/display-report.do?id=P86A-01-00-00-00&src=PR ), finds ...
(Date:11/24/2015)... SAN DIEGO , Nov. 24, 2015 Halozyme Therapeutics, ... Jaffray Healthcare Conference in New York on ... Dr. Helen Torley , president and CEO, will provide a ... New York at 1:00 p.m. ET/10:00 a.m. ... communication and investor relations, will provide a corporate overview. --> ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... year and one of the premier annual events for pharmaceutical manufacturing: 2015 Annual ... November 2015, where ISPE hosted the largest number of attendees in more than ...
(Date:11/24/2015)... -- --> --> ... Market by Product & Services (Primer, Probe, Custom Oligos, ... End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - Global ... expected to reach USD 1,918.6 Million by 2020 from ... 10.1% during the forecast period. Browse 183 ...
Breaking Biology Technology:
Cached News: